Mouse SPNS2 Functions as a Sphingosine-1-Phosphate Transporter in Vascular Endothelial Cells

被引:176
作者
Hisano, Yu [1 ]
Kobayashi, Naoki [1 ]
Yamaguchi, Akihito [1 ,2 ]
Nishi, Tsuyoshi [1 ,2 ]
机构
[1] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Ibaraki, Osaka, Japan
[2] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan
来源
PLOS ONE | 2012年 / 7卷 / 06期
关键词
SPHINGOSINE; 1-PHOSPHATE; MAST-CELLS; LYMPHOCYTE EGRESS; IMMUNOMODULATOR FTY720; PLATELETS; RECEPTOR; RELEASE; BLOOD; ERYTHROCYTES; METABOLISM;
D O I
10.1371/journal.pone.0038941
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Sphingosine-1-phosphate (S1P), a sphingolipid metabolite that is produced inside the cells, regulates a variety of physiological and pathological responses via S1P receptors (S1P1-5). Signal transduction between cells consists of three steps; the synthesis of signaling molecules, their export to the extracellular space and their recognition by receptors. An S1P concentration gradient is essential for the migration of various cell types that express S1P receptors, such as lymphocytes, pre-osteoclasts, cancer cells and endothelial cells. To maintain this concentration gradient, plasma S1P concentration must be at a higher level. However, little is known about the molecular mechanism by which S1P is supplied to extracellular environments such as blood plasma. Here, we show that SPNS2 functions as an S1P transporter in vascular endothelial cells but not in erythrocytes and platelets. Moreover, the plasma S1P concentration of SPNS2-deficient mice was reduced to approximately 60% of wild-type, and SPNS2-deficient mice were lymphopenic. Our results demonstrate that SPNS2 is the first physiological S1P transporter in mammals and is a key determinant of lymphocyte egress from the thymus.
引用
收藏
页数:11
相关论文
共 55 条
[1]   Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720 [J].
Allende, ML ;
Sasaki, T ;
Kawai, H ;
Olivera, A ;
Mi, YD ;
van Echten-Deckert, G ;
Hajdu, R ;
Rosenbach, M ;
Keohane, CA ;
Mandala, S ;
Spiegel, S ;
Proia, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) :52487-52492
[2]   The immunomodulator FTY720 is phosphorylated and released from platelets [J].
Anada, Yoshihiro ;
Igarashi, Yasuyuki ;
Kihara, Akio .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 568 (1-3) :106-111
[3]   Sphingosine 1-phosphate-related metabolism in the blood vessel [J].
Aoki, S ;
Yatomi, Y ;
Ohta, M ;
Osada, M ;
Kazama, F ;
Satoh, K ;
Nakahara, K ;
Ozaki, Y .
JOURNAL OF BIOCHEMISTRY, 2005, 138 (01) :47-55
[4]   HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects [J].
Argraves, Kelley M. ;
Argraves, W. Scott .
JOURNAL OF LIPID RESEARCH, 2007, 48 (11) :2325-2333
[5]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[6]   Lipid phosphate phosphatase 3 enables efficient thymic egress [J].
Breart, Beatrice ;
Ramos-Perez, Willy D. ;
Mendoza, Alejandra ;
Salous, Abdelghaffar K. ;
Gobert, Michael ;
Huang, Yong ;
Adams, Ralf H. ;
Lafaille, Juan J. ;
Escalante-Alcalde, Diana ;
Morris, Andrew J. ;
Schwab, Susan R. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (06) :1267-1278
[7]   Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology [J].
Brinkmann, Volker .
PHARMACOLOGY & THERAPEUTICS, 2007, 115 (01) :84-105
[8]   Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M [J].
Christoffersen, Christina ;
Obinata, Hideru ;
Kumaraswamy, Sunil B. ;
Galvani, Sylvain ;
Ahnstrom, Josefin ;
Sevvana, Madhumati ;
Egerer-Sieber, Claudia ;
Muller, Yves A. ;
Hla, Timothy ;
Nielsen, Lars B. ;
Dahlback, Bjorn .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (23) :9613-9618
[9]   Mechanisms of Fingolimod's Efficacy and Adverse Effects in Multiple Sclerosis [J].
Cohen, Jeffrey A. ;
Chun, Jerold .
ANNALS OF NEUROLOGY, 2011, 69 (05) :759-777
[10]  
FINDLATER GS, 1993, J ANAT, V183, P121